Paclitaxel-coated balloon angioplasty for lower extremity revascularization: A new way to fight in-stent restenosis

Journal of Cardiovascular Surgery

Volumn 51, Issue 4, 2010, Pages 567-571

  Manzi, M ^a   Cester, G ^a   Palena, L M ^a  

^a Interventional Radiology Unit   (Italy)

Author keywords

Coronary restenosis; Drug eluting stents; Peripheral vascular diseases

Indexed keywords

PACLITAXEL;

CELL CULTURE; CORONARY ARTERY; DRUG DELIVERY SYSTEM; FEMORAL ARTERY; HUMAN; IN-STENT RESTENOSIS; INTIMA; LEG REVASCULARIZATION; MITOSIS; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; POPLITEAL ARTERY; REVIEW;

ANGIOPLASTY, BALLOON; ANIMALS; ARTERIAL OCCLUSIVE DISEASES; CARDIOVASCULAR AGENTS; CONSTRICTION, PATHOLOGIC; DRUG-ELUTING STENTS; EVIDENCE-BASED MEDICINE; HUMANS; LOWER EXTREMITY; PACLITAXEL; PROSTHESIS DESIGN; RECURRENCE; TREATMENT OUTCOME;

EID: 78649314627     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (26)

1. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). European journal of vascular and endovascular surgery : the official journal of the European Society for Vascular Surgery 2007;33(Suppl 1):S1-75.
2. Schillinger M, Sabeti S, Loewe C, Dick P, Amighi J, Mlekusch W et al. Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery. N Engl J Med 2006;354:1879-88.
3. Davies MG, Bismuth J, Saad WE, Naoum JJ, Peden EK, Lumsden AB. Outcomes of interventions for recurrent disease after endoluminal intervention for superficial femoral artery disease. J Vasc Surg 2010 [Epub ahead of print].
4. Kearney M, Pieczek A, Haley L, Losordo DW, Andres V, Schainfeld R et al. Histopathology of in-stent restenosis in patients with peripheral artery disease. Circulation 1997;95:1998-2002.
5. Rogers JH, Laird JR. Overview of new technologies for lower extremity revascularization. Circulation 2007;116:2072-85.
6. Waksman R, Pakala R. Drug-eluting balloon: the comeback kid? Circulation: Cardiovascular Interventions 2009;2:352-8.
7. Sharma S, Kukreja N, Christopoulos C, Gorog DA. Drug-eluting balloon: new tool in the box. Expert Rev Med Devices 2010;7:381-8.
8. De Labriolle A, Pakala R, Bonello L, Lemesle G, Scheinowitz M, Waksman R. Paclitaxel-eluting balloon: from bench to bed. Catheter Cardiovasc Interv 2009;73:643-52.
9. Axel DI, Kunert W, Goggelmann C, Oberhoff M, Herdeg C, Kuttner A et al. Paclitaxel inhibits arterial smooth muscle cell proliferation and migration in vitro and in vivo using local drug delivery. Circulation 1997;96:636-45.
10. Scheller B, Speck U, Romeike B, Schmitt A, Sovak M, Bohm M et al. Contrast media as carriers for local drug delivery. Successful inhibition of neointimal proliferation in the porcine coronary stent model. Eur Heart J 2003;24:1462-7.
11. Scheller B, Speck U, Schmitt A, Bohm M, Nickenig G. Addition of paclitaxel to contrast media prevents restenosis after coronary stent implantation. J Am Coll Cardiol 2003;42:1415-20.
12. Speck U, Scheller B, Abramjuk C, Breitwieser C, Dobberstein J, Boehm M et al. Neointima inhibition: comparison of effectiveness of non-stent-based local drug delivery and a drug-eluting stent in porcine coronary arteries. Radiology 2006;240:411-8.
13. Rowinsky EK, Donehower RC. Paclitaxel (taxol). N Engl J Med 1995;332:1004-14.
14. Speck U, Scheller B, Abramjuk C, Grossmann S, Mahnkopf D, Simon O. Inhibition of restenosis in stented porcine coronary arteries: uptake of Paclitaxel from angiographic contrast media. Invest Radiol 2004;39:182-6.
15. Scheller B, Speck U, Abramjuk C, Bernhardt U, Böhm M, Nickenig G. Paclitaxel balloon coating, a novel method for prevention and therapy of restenosis. Circulation 2004;110:810-4.
16. Posa A, Hemetsberger R, Petnehazy O, Petrasi Z, Testor M, Glogar D et al. Attainment of local drug delivery with paclitaxel-eluting balloon in porcine coronary arteries. Coron Artery Dis 2008;19: 243-7.
17. Cremers B, Biedermann M, Mahnkopf D, Bohm M, Scheller B. Comparison of two different paclitaxel-coated balloon catheters in the porcine coronary restenosis model. Clin Res Cardiol 2009;98:325-30.
18. Cremers B, Speck U, Kaufels N, Mahnkopf D, Kuhler M, Bohm M et al. Drug-eluting balloon: very short-term exposure and overlapping. Thromb Haemost 2009;101:201-6.
19. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med 2006;355:2113-24.
20. Scheller B, Hehrlein C, Bocksch W, Rutsch W, Haghi D, Dietz U et al. Two year follow-up after treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. Clin Res Cardiol 2008;97:773-81.
21. Fanggiday JC, Stella PR, Guyomi SH, Doevendans PA. Safety and efficacy of drug-eluting balloons in percutaneous treatment of bifurcation lesions: the DEBIUT (drug-eluting balloon in bifurcation Utrecht) registry. Catheter Cardiovasc Interv 2008;71:629-35.
22. Unverdorben M, Vallbracht C, Cremers B, Heuer H, Hengstenberg C, Maikowski C et al. Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosis. Circulation 2009;119:2986-94.
23. Albrecht T, Speck U, Baier C, Wolf K-J, Böhm M, Scheller B. Reduction of stenosis due to intimal hyperplasia after stent supported angioplasty of peripheral arteries by local administration of paclitaxel in swine. Invest Radiol 2007;42:579-85.
24. Virmani R, Kolodgie FD, Farb A, Lafont A. Drug eluting stents: are human and animal studies comparable? Heart 2003;89:133-8.
25. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi J- P et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008;358:689-99.
26. Werk M, Langner S, Reinkensmeier B, Boettcher H-F, Tepe G, Dietz U et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008;118:1358-65.